Cargando…
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes
BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602856/ https://www.ncbi.nlm.nih.gov/pubmed/28915881 http://dx.doi.org/10.1186/s12933-017-0599-2 |
_version_ | 1783264634948550656 |
---|---|
author | Maddaloni, Ernesto Xia, Yu Park, Kyoungmin D’Eon, Stephanie Tinsley, Liane J. St-Louis, Ronald Khamaisi, Mogher Li, Qian King, George L. Keenan, Hillary A. |
author_facet | Maddaloni, Ernesto Xia, Yu Park, Kyoungmin D’Eon, Stephanie Tinsley, Liane J. St-Louis, Ronald Khamaisi, Mogher Li, Qian King, George L. Keenan, Hillary A. |
author_sort | Maddaloni, Ernesto |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with ≥50 years of T1D, the 50-Year Joslin Medalists (J50M). METHODS: CD45 bright/CD14+/OCN+ cells in the circulating mononuclear blood cell fraction were quantified by flow cytometry and reported as percentage of CD45 bright cells. Mechanisms were studied by inducing OCN expression in human monocytes in vitro. RESULTS: Subjects without history of CVD (n = 16) showed lower levels of OCN+ monocytes than subjects with CVD (n = 14) (13.1 ± 8.4% vs 19.9 ± 6.4%, p = 0.02). OCN+ monocytes level was inversely related to total high density lipoprotein (HDL) cholesterol levels (r = −0.424, p = 0.02), large (r = −0.413, p = 0.02) and intermediate (r = −0.445, p = 0.01) HDL sub-fractions, but not to small HDL. In vitro, incubation with OxLDL significantly increased the number of OCN+ monocytes (p < 0.01). This action of OxLDL was significantly reduced by the addition of HDL in a concentration dependent manner (p < 0.001). Inhibition of the scavenger receptor B1 reduced the effects of both OxLDL and HDL (p < 0.05). CONCLUSIONS: Low OCN+ monocytes levels are associated with lack of CVD in people with long duration T1D. A possible mechanism for the increased OCN+ monocytes could be the elevated levels of oxidized lipids due to diabetes which may be inhibited by HDL. These findings suggest that circulating OCN+ monocytes could be a marker for vascular disease in diabetic patients and possibly modified by HDL elevation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0599-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5602856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56028562017-09-20 High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes Maddaloni, Ernesto Xia, Yu Park, Kyoungmin D’Eon, Stephanie Tinsley, Liane J. St-Louis, Ronald Khamaisi, Mogher Li, Qian King, George L. Keenan, Hillary A. Cardiovasc Diabetol Original Investigation BACKGROUND: Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes (T1D). A pro-calcific drift of circulating monocytes has been linked to vascular calcification and is marked by the surface expression of osteocalcin (OCN). We studied OCN+ monocytes in a unique population with ≥50 years of T1D, the 50-Year Joslin Medalists (J50M). METHODS: CD45 bright/CD14+/OCN+ cells in the circulating mononuclear blood cell fraction were quantified by flow cytometry and reported as percentage of CD45 bright cells. Mechanisms were studied by inducing OCN expression in human monocytes in vitro. RESULTS: Subjects without history of CVD (n = 16) showed lower levels of OCN+ monocytes than subjects with CVD (n = 14) (13.1 ± 8.4% vs 19.9 ± 6.4%, p = 0.02). OCN+ monocytes level was inversely related to total high density lipoprotein (HDL) cholesterol levels (r = −0.424, p = 0.02), large (r = −0.413, p = 0.02) and intermediate (r = −0.445, p = 0.01) HDL sub-fractions, but not to small HDL. In vitro, incubation with OxLDL significantly increased the number of OCN+ monocytes (p < 0.01). This action of OxLDL was significantly reduced by the addition of HDL in a concentration dependent manner (p < 0.001). Inhibition of the scavenger receptor B1 reduced the effects of both OxLDL and HDL (p < 0.05). CONCLUSIONS: Low OCN+ monocytes levels are associated with lack of CVD in people with long duration T1D. A possible mechanism for the increased OCN+ monocytes could be the elevated levels of oxidized lipids due to diabetes which may be inhibited by HDL. These findings suggest that circulating OCN+ monocytes could be a marker for vascular disease in diabetic patients and possibly modified by HDL elevation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0599-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-16 /pmc/articles/PMC5602856/ /pubmed/28915881 http://dx.doi.org/10.1186/s12933-017-0599-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Maddaloni, Ernesto Xia, Yu Park, Kyoungmin D’Eon, Stephanie Tinsley, Liane J. St-Louis, Ronald Khamaisi, Mogher Li, Qian King, George L. Keenan, Hillary A. High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title | High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title_full | High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title_fullStr | High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title_full_unstemmed | High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title_short | High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
title_sort | high density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602856/ https://www.ncbi.nlm.nih.gov/pubmed/28915881 http://dx.doi.org/10.1186/s12933-017-0599-2 |
work_keys_str_mv | AT maddaloniernesto highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT xiayu highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT parkkyoungmin highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT deonstephanie highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT tinsleylianej highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT stlouisronald highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT khamaisimogher highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT liqian highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT kinggeorgel highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes AT keenanhillarya highdensitylipoproteinmodulatesosteocalcinexpressionincirculatingmonocytesapotentialprotectivemechanismforcardiovasculardiseaseintype1diabetes |